Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 43.05 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 45.24 | Oscillator | Neutral |
| Williams %R (14) | -42.96 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.04 (Hist 0.01) | Oscillator | Buy |
| Average Directional Index (14) | 34.64 (+DI 17.8 / -DI 26.5) | Trend | Strong Sell |
Current price $0.4152
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 13, 26 |
| EMA 20 | 0.45 | MA | Strong Sell |
| SMA 20 | 0.45 | MA | Sell |
| EMA 50 | 0.53 | MA | Strong Sell |
| SMA 50 | 0.54 | MA | Strong Sell |
| SMA 200 | 0.82 | MA | Strong Sell |
| Benchmark |
| maintain |
| Speculative Buy |
| Speculative Buy |
| Jul 28, 26 | BTIG | maintain | Buy | Buy |
| Jun 17, 26 | TD Cowen | maintain | Buy | Buy |
| Jun 16, 26 | BTIG | maintain | Buy | Buy |
| Jun 11, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 8, 26 | BTIG | maintain | Buy | Buy |
| Jun 1, 26 | Benchmark | maintain | Speculative Buy | Speculative Buy |
| May 26, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 14, 26 | TD Cowen | maintain | Buy | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 6, 26 | Coward D Scott | director | A-Award | 125,000 @ $0.478 | $59.75K |
| Oct 6, 26 | Kuznik Paul Brian | director | A-Award | 125,000 @ $0.478 | $59.75K |
| Sep 22, 26 | Kuznik Paul Brian | director | 0 | — | |
| Sep 22, 26 | Kuznik Paul Brian | director | 0 | — | |
| Sep 22, 26 | Coward D Scott | 0 | — | ||
| Sep 14, 26 | Jones Keith Anthony | director | P-Purchase | 10,000 @ $0.562 | $5.62K |
| Aug 20, 26 | Jones Keith Anthony | director | P-Purchase | 10,000 @ $0.693 | $6.93K |
| Aug 17, 26 | Jones Keith Anthony | director | P-Purchase | 30,000 @ $0.594 | $17.82K |
TTM vs. 5-year historical average (annual ratios)
| Metric | HUMA | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.9x | -7.8x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -1.0x | EPS est. -0.41 | Elevated |
| Price / Book | 3.3x | 12.7x | Discount |
| Price / Sales | 57.0x | 88.6x | Discount |
| EV / EBITDA | -1.4x | 4.9x | Discount |
| Return on equity | -938.2% | — | Weak |
| Gross margin | -666.8% | -1184.1% | Below hist. |
| Debt / Equity | 2.12 | 5.13 | Levered |
| Piotroski / Altman Z | 3/9 | Z -8.62 | Distress |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 7, 2026 | 2026-10-07 16:06:03 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:05:04 | View |
| 3 | Sep 28, 2026 | 2026-09-28 16:07:03 | View |
| 3 | Sep 28, 2026 | 2026-09-28 16:06:05 | View |
| 8-K | Sep 28, 2026 | 2026-09-28 16:05:14 | View |
| 4 | Sep 15, 2026 | 2026-09-15 16:05:04 | View |
| 25-NSE | Aug 25, 2026 | 2026-08-25 16:18:08 | View |
| 4 | Aug 21, 2026 | 2026-08-21 16:05:06 | View |
| 4 | Aug 19, 2026 | 2026-08-19 16:00:03 | View |
| SC 13D/A | Aug 18, 2026 | 2026-08-18 09:15:11 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
- The presenter, Dr. Roy-Chaudhury said, “These results give the nephrology community a strong reason to rethink our approach to access decisions for women and, once approved by the FDA, to consider the ATEV as a meaningful new option.”
Humacyte, Inc. (HUMA) closed at $0.41 in the latest trading session, marking a +1.28% move from the prior day.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 12, 2026 | -0.11 | -0.16 | Miss -41.0% | $406.0K |
| May 13, 2026 | -0.10 | -0.09 | Beat 10.0% | $495.0K |
| Mar 27, 2026 | -0.13 | -0.13 | Beat 0.0% | $467.0K |
| Nov 12, 2025 | -0.17 | -0.14 | Beat 17.6% | $753.0K |
| Aug 11, 2025 | -0.15 | -0.24 | Miss -60.0% | $301.0K |
| May 13, 2025 | -0.19 | 0.28 | Beat 247.4% | $517.0K |